Nova Mentis Ownership
NMLSF Stock | USD 0.03 0 6.14% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Nova |
Nova Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.02. Nova Mentis Life last dividend was issued on the 26th of June 2020. The entity had 1:4 split on the 26th of June 2020. Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Nova Mentis is traded on OTC Exchange in the United States.The quote for Nova Mentis Life is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nova Mentis Life contact William Rascan at 778 819 0244 or learn more at https://www.novamentis.ca.Currently Active Assets on Macroaxis
Other Information on Investing in Nova Pink Sheet
Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.